Cargando…
Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial
BACKGROUND: Ketorolac has been associated with a lower risk of recurrence in retrospective studies, especially in patients with positive inflammatory markers. It is still unknown whether a single dose of pre-incisional ketorolac can prolong recurrence-free survival. METHODS: The KBC trial is a multi...
Autores principales: | Forget, Patrice, Bouche, Gauthier, Duhoux, Francois P., Coulie, Pierre G., Decloedt, Jan, Dekleermaker, Alain, Guillaume, Jean-Edouard, Ledent, Marc, Machiels, Jean-Pascal, Mustin, Véronique, Swinnen, Walter, van Maanen, Aline, Vander Essen, Lionel, Verougstraete, Jean-Christophe, De Kock, Marc, Berliere, Martine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892544/ https://www.ncbi.nlm.nih.gov/pubmed/31800611 http://dx.doi.org/10.1371/journal.pone.0225748 |
Ejemplares similares
-
Characterization of Preoperative, Postsurgical, Acute and Chronic Pain in High Risk Breast Cancer Patients
por: Forget, Patrice, et al.
Publicado: (2020) -
Correction: Tamoxifen and Ovarian Function
por: Berliere, Martine, et al.
Publicado: (2013) -
Tamoxifen and Ovarian Function
por: Berliere, Martine, et al.
Publicado: (2013) -
Antivascular Therapy for Epithelial Ovarian Cancer
por: Duhoux, Francois P., et al.
Publicado: (2010) -
Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer
por: Migeotte, A., et al.
Publicado: (2021)